Showing results (561-570 of 590) with videos related to
Sort By:
Pageof 59
Blood|April 21, 2007
Flt3-dependent transformation by inactivating c-Cbl mutations in AMLBülent Sargin, Chunaram Choudhary, Nicola Crosetto, et al.Science Signaling|December 24, 2009
Regulation of epidermal growth factor receptor trafficking by lysine deacetylase HDAC6Yonathan Lissanu Deribe, Philipp Wild, Akhila Chandrashaker, et al.Molecular Cancer Therapeutics|July 22, 2017
The IGF1R/INSR Inhibitor BI 885578 Selectively Inhibits Growth of IGF2-Overexpressing Colorectal Cancer Tumors and Potentiates the Efficacy of Anti-VEGF TherapyMichael P Sanderson, Marco H Hofmann, Pilar Garin-Chesa, et al.Rheumatology (Oxford, England)|February 5, 2025
A phase 2 randomized trial of safety and pharmacokinetics of IgPro20 and IgPro10 in patients with diffuse cutaneous systemic sclerosisChristopher P Denton, Otylia Kowal-Bielecka, Susanna M Proudman, et al.The Journal of Pharmacology and Experimental Therapeutics|October 14, 2022
Pharmacodynamic and Antitumor Activity of BI 836880, a Dual Vascular Endothelial Growth Factor and Angiopoietin 2 Inhibitor, Alone and Combined with Programmed Cell Death Protein-1 InhibitionIrmgard Hofmann, Anke Baum, Marco H Hofmann, et al.Journal of Medicinal Chemistry|July 14, 2023
Discovery of BI 7446: A Potent Cyclic Dinucleotide STING Agonist with Broad-Spectrum Variant Activity for the Treatment of CancerChristian A Kuttruff, Martin Fleck, Sebastian Carotta, et al.Nature Communications|June 29, 2017
Neurovascular EGFL7 regulates adult neurogenesis in the subventricular zone and thereby affects olfactory perceptionFrank Bicker, Verica Vasic, Guilherme Horta, et al.ESMO Open|May 6, 2023
Smaller panel, similar results: genomic profiling and molecularly informed therapy in pancreatic cancerT M Reissig, I Tzianopoulos, S-T Liffers, et al.Proceedings of the National Academy of Sciences of the United States of America|March 12, 2025
SOS1 inhibitor BI-3406 shows in vivo antitumor activity akin to genetic ablation and synergizes with a KRASG12D inhibitor in KRAS LUADFernando C Baltanás, Maximilian Kramer-Drauberg, Rósula García-Navas, et al.Science Translational Medicine|June 11, 2025
AMPAR inhibition lowers S1P in human blood and improves murine autoimmune neuroinflammation by blocking T cell egress from lymph nodesBeatrice Wasser, Manuela Ecker, Nicholas Hanuscheck, et al.Pageof 59